RHON-KLINIKUM AG Unsponsored ADR
RKAGY · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 1.12 | 0.32 | -3.39 | 0.02 |
| FCF Yield | 7.60% | 7.05% | -2.08% | 1.92% |
| EV / EBITDA | 5.09 | 5.12 | 9.14 | 10.54 |
| Quality | ||||
| ROIC | 2.61% | 2.36% | 2.03% | 2.41% |
| Gross Margin | 10.77% | 10.16% | 69.12% | 11.48% |
| Cash Conversion Ratio | 2.82 | 2.82 | 1.64 | 3.56 |
| Growth | ||||
| Revenue 3-Year CAGR | 3.33% | -2.74% | 2.06% | 6.86% |
| Free Cash Flow Growth | 23.81% | 373.37% | -185.79% | 20.86% |
| Safety | ||||
| Net Debt / EBITDA | -1.07 | -0.48 | 0.83 | 0.33 |
| Interest Coverage | 14.16 | 10.92 | 8.81 | 9.54 |
| Efficiency | ||||
| Inventory Turnover | 38.01 | 38.44 | 13.40 | 12.99 |
| Cash Conversion Cycle | 88.28 | 48.17 | 56.85 | 29.50 |